Increased mean platelet volume after oestrogen replacement therapy

被引:26
作者
Ranganath, LR [1 ]
Christofides, J [1 ]
Semple, MJ [1 ]
机构
[1] EPSOM GEN HOSP, DEPT HAEMATOL, SURREY KT18 7EG, ENGLAND
关键词
hormone replacement therapy; platelet membrane fatty acids;
D O I
10.1177/000456329603300612
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The effect of hormone replacement therapy (HRT) on platelet size was examined in 38 post-menopausal women before and at end of a 6 week period of HRT. Subjects were treated with cyclical L-norgestrel 75 mg daily from days 17 to 28 of a 28-day cycle combined with continuous conjugated equine oestrogens 0.625 mg daily. Platelet-rich plasma was obtained to measure platelet indices by Coulter analysis. Plasma measurements of luteinizing hormone, follicle stimulating hormone and 17 beta-oestradiol were measured by immunoassays. Platelet membrane fatty acids were measured by gas-liquid chromatography. A significant reduction in platelet membrane linoleic acid, di-homo-gamma-linoleic acid and arachidonic acid of 8.1%, 14.3% and 17.8%, respectively was noted after 6 weeks of HRT (P < 0.01). There was an increase in the platelet count (not significant) and platelet volume (MPV) (P < 0.05) after 6 weeks of hormone therapy. HRT appears to increase mean platelet volume which may indicate an increase in platelet reactivity. There was no correlation between the changes in mean platelet volume and membrane fatty acid changes in platelets after such therapy.
引用
收藏
页码:555 / 560
页数:6
相关论文
共 23 条
[1]   RETROSPECTIVE ANALYSIS OF PLATELET NUMBERS AND VOLUMES IN NORMAL-PREGNANCY AND IN PREECLAMPSIA [J].
AHMED, Y ;
VANIDDEKINGE, B ;
PAUL, C ;
SULLIVAN, MHF ;
ELDER, MG .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1993, 100 (03) :216-220
[2]   THE EFFECT OF OLIVE OIL SUPPLEMENTATION ON HUMAN PLATELET-FUNCTION, SERUM CHOLESTEROL-RELATED VARIABLES AND PLASMA-FIBRINOGEN CONCENTRATIONS - A PILOT-STUDY [J].
BARRADAS, MA ;
CHRISTOFIDES, JA ;
JEREMY, JY ;
MIKHAILIDIS, DP ;
FRY, DE ;
DANDONA, P .
NUTRITION RESEARCH, 1990, 10 (04) :403-411
[3]   PLATELET SIZE IN HEALTH AND HEMATOLOGIC DISEASE [J].
BESSMAN, JD ;
WILLIAMS, LJ ;
GILMER, PR .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1982, 78 (02) :150-153
[4]   EFFECTS OF NATURAL ESTROGEN REPLACEMENT THERAPY ON MENOPAUSAL SYMPTOMS AND BLOOD-CLOTTING [J].
COOPE, J ;
THOMSON, JM ;
POLLER, L .
BRITISH MEDICAL JOURNAL, 1975, 4 (5989) :139-143
[5]  
GILES C, 1981, BRIT J HAEMATOL, V48, P31
[6]   ESTROGEN IN PATIENTS WITH PROSTATIC-CANCER - AN ASSESSMENT OF THE RISKS AND BENEFITS [J].
HENRIKSSON, P .
DRUG SAFETY, 1991, 6 (01) :47-53
[7]   REDUCTION OF NONSPECIFIC SERUM RESPONSES IN HUMAN PITUITARY GONADOTROPIN RADIOIMMUNOASSAYS [J].
HUNTER, WM ;
BENNIE, JG .
JOURNAL OF ENDOCRINOLOGY, 1979, 80 (01) :59-68
[8]  
HUTTON RA, 1989, POSTGRADUATE HAEMATO, P560
[9]   ARACHIDONIC-ACID METABOLISM BY PLATELETS OF DIFFERING SIZE [J].
JAKUBOWSKI, JA ;
THOMPSON, CB ;
VAILLANCOURT, R ;
VALERI, CR ;
DEYKIN, D .
BRITISH JOURNAL OF HAEMATOLOGY, 1983, 53 (03) :503-511
[10]   PHARMACOKINETICS OF LEVONORGESTREL AND ETHINYLESTRADIOL IN 9 WOMEN WHO RECEIVED A LOW-DOSE ORAL-CONTRACEPTIVE OVER A TREATMENT PERIOD OF 3 MONTHS AND, AFTER A WASH-OUT PHASE, A SINGLE ORAL-ADMINISTRATION OF THE SAME CONTRACEPTIVE FORMULATION [J].
KUHNZ, W ;
ALYACOUB, G ;
FUHRMEISTER, A .
CONTRACEPTION, 1992, 46 (05) :455-469